| Title |
Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions
|
|---|---|
| Published in |
PLOS ONE, August 2012
|
| DOI | 10.1371/journal.pone.0043257 |
| Pubmed ID | |
| Authors |
Maria A. Cantu, Philip J. Lupo, Mrinalini Bilgi, M. John Hicks, Carl E. Allen, Kenneth L. McClain |
| Abstract |
There is little data on treatment of Langerhans cell histiocytosis (LCH) in adults. Available data is on small numbers of patients with short follow-up times and no comparison of results from different treatment regimens. We analyzed the responses of adult LCH patients with bone lesions to three primary chemotherapy treatments to define the optimal one. |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 19% |
| Professor > Associate Professor | 9 | 16% |
| Other | 7 | 12% |
| Student > Postgraduate | 7 | 12% |
| Professor | 4 | 7% |
| Other | 11 | 19% |
| Unknown | 8 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 67% |
| Nursing and Health Professions | 2 | 4% |
| Physics and Astronomy | 1 | 2% |
| Agricultural and Biological Sciences | 1 | 2% |
| Social Sciences | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 13 | 23% |